Gene: EPN1
Official Full Name: epsin 1provided by HGNC
Gene Summary: This gene encodes a member of the epsin protein family. The encoded protein binds clathrin and is involved in the endocytosis of clathrin-coated vesicles. Loss of function of this gene is associated with reduced tumor growth and progression in certain cancer types. [provided by RefSeq, Mar 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01041 | EPN1 Knockout cell line (HeLa) | Human | EPN1 | 1:3~1:6 | Negative | Online Inquiry |
KO26937 | EPN1 Knockout cell line (HCT 116) | Human | EPN1 | 1:2~1:4 | Negative | Online Inquiry |
KO26938 | EPN1 Knockout cell line (HEK293) | Human | EPN1 | 1:3~1:6 | Negative | Online Inquiry |
KO26939 | EPN1 Knockout cell line (A549) | Human | EPN1 | 1:3~1:4 | Negative | Online Inquiry |
EPN1 Gene Knockout Cell Lines are genetically modified cell lines where the EPN1 gene has been deliberately disrupted or inactivated. EPN1, or Epsin-1, is a critical protein involved in endocytosis, the cellular process of internalizing molecules, signaling proteins, and nutrients. By creating knockout models of this gene, researchers can explore its functional roles in cell biology, disease mechanisms, and potential therapeutic targets.
These cell lines operate by using CRISPR-Cas9 technology to precisely edit the genomic sequence of the EPN1 gene, leading to a loss of function. The absence of EPN1 reveals insights into cell signaling pathways, particularly those associated with membrane trafficking and cellular responses to various stimuli. Through experiments with EPN1 knockout lines, researchers can illuminate the contributions of this protein to pathologies such as cancer, neurodegeneration, and metabolic disorders, aiding in the identification of critical therapeutic targets.
The scientific importance of EPN1 Gene Knockout Cell Lines lies in their utility for both basic research and translational applications. They provide a model system for understanding the intricate mechanisms of endocytosis and its dysregulation in disease. Furthermore, these cell lines can be utilized in drug discovery processes, allowing researchers to test the efficacy of compounds aimed at modulating endocytic pathways.
What sets EPN1 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability, attributed to advanced gene editing techniques that yield consistent knockout models with minimal off-target effects. This specificity ensures that the observed phenotypes stem directly from the absence of EPN1, thereby enhancing the robustness of experimental conclusions.
For researchers and clinicians, employing EPN1 Gene Knockout Cell Lines presents invaluable opportunities to study gene function, model disease states accurately, and develop innovative therapeutic strategies. The knowledge gained from these studies can ultimately lead to significant advancements in understanding human health and disease.
Our company specializes in providing high-quality, rigorously validated genetic models that empower life science research. With a commitment to excellence, we ensure our products meet the evolving needs of the scientific community, fostering discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.